Inve
IN ⇄ US

Jyothy Labs share price & results

Jyothy Labs· Fast Moving Consumer Goods

Results to
Jun 2026
Latest analysed call
Q1 FY27
Ownership as of
Sept 2026

Indian FMCG maker of home & personal care brands: Ujala, Exo, Maxo, Margo, Henko, Mr. White.

Company research is public. Sign in to keep your own companies, notes and cases.

Inve AI Signals on JYOTHYLAB
Direct bridge to live research & tools watching Jyothy Labs
Guidance Hit Rate
11 targets · 0% hit rate 0 achieved · 6 active →
Segment Shift
5 segments tracked See revenue & margin mix below →
Reverse DCF
Reality Gap Ready Test priced-in growth in DCF tool →
Concall & Tone
Q1 FY27 analysed Read claims, qualifiers & Q&A →

Price & Snapshot

₹184.83 +7.52% · +₹12.92

Last close 2 Nov 2026 · NSE · INR · Source: Inve

Performance −41.2% 1Y

₹200₹250₹300Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 12 Nov 2025Q3 FY26 — 9 Feb 2026Q4 FY26 — 4 May 2026Q1 FY27 — 12 Aug 2026

1Y: ₹314.5 on 31 Oct 2025 → ₹184.83. High ₹315.85 (3 Nov 2025), low ₹171.91 (30 Oct 2026).

Previous close
₹171.91
Market cap
₹6.8k Cr
52-week range
₹171.91 – ₹315.85
One year
−41.48%

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue773 ₹ crore+2.9% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin8.0 %−9.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit48.0 ₹ crore−50.5% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equityUnavailable−2.2 ptsFY Mar 2025 vs FY Mar 2024Trailing twelve monthsTTM · period unavailableNot in the analysed materials. No older figure is substituted.
Free cash flow marginUnavailable−7.2 ptsFY Mar 2025 vs FY Mar 2024Fiscal yearFY · period unavailableNot in the analysed materials. No older figure is substituted.
Revenue growth (YoY)Unavailable−7.6 ptsFY Mar 2025 vs FY Mar 2024Trailing twelve monthsTTM · period unavailableNot in the analysed materials. No older figure is substituted.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Business Mix

Where revenue comes from

3 operating segments · As of 30 Jun 2026

Fabric Care 51.6% · ₹398.89 Cr +6.0pp mix
Home Care 36.2% · ₹280.19 Cr
Personal Care 12.2% · ₹94.32 Cr +2.8pp mix

Explore full multi-period segment shift & margins →

Guidance

What management said, and what became of it

0 of 5 judged targets kept · 6 open · verdicts reflect calls analysed to Q1 FY27.

Jyothy Labs management guidance track record on Inve: 11 targets tracked across analysed earnings calls (0 achieved, 5 missed, 6 open).

Watch execution in Operations & Margins (1 delayed/missed).

TargetOriginal wordingSaidLatest callVerdict
Operations Operating EBITDA Margin16% to 17% for the next financial year
Call transcript, Q3 FY25 · 3 Feb 2025		Q3 FY25Q1 FY27:8.4% - Target period FY26 has passed. New guidance issued for FY27.
Call transcript, Q1 FY27 · 12 Aug 2026		Missed
Growth Volume-Value Growth Gap2% to 3% gap over a fairly long period of time
Call transcript, Q3 FY25 · 3 Feb 2025		Q3 FY25Q1 FY27:2.8% gap (Value growth 8.1%, Volume growth 5.3% ex-Pril/FA). Within original target range.
Call transcript, Q1 FY27 · 12 Aug 2026		On Track

Source: Inve Guidance Tracker for Jyothy Labs · to Q1 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

5 of Jyothy Labs's 11 targets were missed. See which ones, and which are quietly gone. The 2 above are the free sample; 9 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Supply chain

Cross-company call evidence

Named counterparties and similar headwinds disclosed on earnings calls.

Products, transactions and disclosed impact

Company disclosures with supporting evidence. Expectations and unresolved details remain qualified.

  • 2026-02-09 · divestiture · reported stage: closed

    Jyothy Labs — divests interest in — JKBL (Joint Venture)

    Party roles: seller of target / transaction asset · closed · agreement: definitive

    Jyothy Labs — divests to — minority shareholder (unnamed; stated in the JKBL divestment context)

    Party roles: seller of target / buyer · closed · agreement: definitive

    Products and services
    Stake in JKBL (Joint Venture) · role: transaction asset · category: business asset
    Disclosed figures
    Loss incurred from the JKBL divestment: about INR 4 crores · disposal loss
    Impact and conditions
    Jyothy Labs: gain loss on disposal · negative outcome · summary claim

    Condition: Loss of about INR 4 crores on the JKBL divestment. The figure comes from the summary note and from the questioner's text ('we had incurred a loss of about INR4 crores'); the answer does not restate it. Accounting period and consolidated/standalone basis are not stated.

    Evidence and remaining questions
    “we sold our stake to the minority shareholder”
    “we sold our stake to the minority shareholder”
    Stake in JKBL (Joint Venture): “we sold our stake to the minority shareholder”
    about INR 4 crores: “Incurred a loss of about INR 4 crores from the divestment.”
    gain loss on disposal: “Incurred a loss of about INR 4 crores from the divestment.”

    Difficult market, cheaper products availability, operational issues, inability to expand meaningfully.

    “Difficult market, cheaper products availability, operational issues, inability to expand meaningfully.”

    Focus on domestic growth and select export markets.

    “Focus on domestic growth and select export markets.”

    More than 10 years spent trying the Bangladesh market

    “More than 10 years, we tried that market.”

    Speaker describes JKBL as 'our subsidiary' through which inroads in the Bangladesh market were made, while the record target is labelled 'JKBL (Joint Venture)' and the question calls it 'our JV'

    “through our subsidiary, JKBL”

    Decision to cut losses and discontinue that operation

    “we thought it prudent to cut our losses and discontinue that operation”

    Decision taken in March last year

    “we took a decision in March last year”

    Speaker states the company came out of the operation after selling its stake

    “we came out of this”

    Questioner states the divestment was done because it did not yield the desired result

    “So we did this divestment because it did not yield the desired result for us.”

    Not established by the available evidence

    • Buyer identity: The buyer is described only as 'the minority shareholder'. It is unnamed, and the source does not state which entity it holds shares in.
    • Selling vehicle: 'We sold our stake' binds to the issuer. Whether Jyothy Labs or another group entity held the stake is not stated.
    • JKBL legal form: The record labels JKBL a Joint Venture, while the speaker calls it 'our subsidiary'. No SUBSIDIARY_OF or JV relation is emitted because the form is unresolved. The ownership percentage and the minority shareholder's stake are not stated.
    • Sale/closing date: 'March last year' qualifies the decision only; the sale's own date and its relation to the decision date are not given, so effective_time_text is null. The calendar year is not stated and is not calculated.
    • Consideration: The record's consideration form is 'undisclosed' and the amount is null. No proceeds or price figure is available. The size of the stake sold is not stated.
    • Disposal loss: The INR 4 crores loss appears in the summary note and in the questioner's (Rushabh's) text; the management answer does not restate it. Whose accounts the loss belongs to, the reporting period, and consolidated or standalone basis are not confirmed.
    • Operational exit effects: Discontinuing the Bangladesh operation is stated, but no separate quantified effect on revenue, profit or other metrics is given.
    • Transcript support: Context was not requested and no passages were supplied. All assertions rest on the original record; there is no independent transcript confirmation of closing.

Counterparties named by Jyothy Labs

  • Jyothy Labs acquires or invests in TTK business.

    Q1 FY27 · terminated · negative

    2 of 4 divisions not aligned with business strategy, significant overlap in remaining 2.

    “On the specific point that you raised about TTK business, yes, we had looked at the business, but the 4 divisions of the business, 2 of them were not aligned to our business strategy, and there was a significant overlap in the remaining 2. So, we did not take it forward.”

  • Jyothy Labs divests to JKBL (Joint Venture).

    Q3 FY26 · closed · neutral

    Difficult market, cheaper products availability, operational issues, inability to expand meaningfully. Focus on domestic growth and select export markets.

    “Okay. My next question is that the divestment of our JV that was JKBL, we had incurred a loss of about INR4 crores. So we did this divestment because it did not yield the desired result for us. So just wanted to know what are the key learnings or what did we make so that we don't repeat them in the future? Thanks for this question, Rushabh. We have put in a number of years in making inroads in Bangladesh market and through our subsidiary, JKBL. More than 10 years, we tried that market. It's a difficult market, and we tried a number of things in order to expand our presence over there. But because of the cheaper products availability over there and the other issues which led to other operational issues, which led to the situation whereby we could not expand it in a meaningful manner. So we thought it prudent to cut our losses and discontinue that operation, and this is why we took a decision in March last year, and we sold our stake to the minority shareholder, and we came out of this.”

  • Jyothy Labs divests to Jyothy Kallol Bangladesh Limited (JKBL).

    Q4 FY25 · closed · neutral

    JKBL had not yielded desired results and stretched management bandwidth without proportionate returns; stronger opportunities exist within India and other export markets.

    Disclosed value: INR 2.1 crores

    “Our decision to divest our 75% stake in JKBL, subject to regulatory approvals, was taken after careful consideration. Despite more than a decade of efforts, JKBL has not yielded the desired results and has stretched management bandwidth without proportionate returns... for a consideration of Rs. 2.1 crore. This transaction has led to a loss of around Rs. 4 crore which is shown under the head exceptional items in Quarter 4 as well as in FY'25. So March 25, 2025 onwards, JKBL is no longer the subsidiary of the company.”

Sector context: matching headwinds

Sector context does not establish a business relationship with Jyothy Labs. Each comparison matches a headwind disclosed by Jyothy Labs in the same calendar reporting quarter.

  • raw material costs · Q1 FY27

    Jyothy Labs reported: Input cost pressures are beginning to emerge with key raw materials, especially soap noodles, witnessing price increases from June onwards.

    Reporting period ended 2026-06-30

    42 other companies · raw material cost

    Hindustan Unilever Limited (HINDUNILVR) reported (period ended 2026-06-30): Inflation in crude-linked derivatives and palm oil continues to impact segments like Home Care and Soaps.

    Nestle India Limited (NESTLEIND) reported (period ended 2026-06-30): Concerns were raised about increasing costs for energy, packaging, oil, shipping disruptions, and currency volatility, with management implementing BCPs.

    Varun Beverages Limited (VBL) reported (period ended 2026-06-30): Inflationary raw material environment affected by West Asia crisis, managed by averaging costs.

    Britannia Industries Limited (BRITANNIA) reported (period ended 2026-06-30): Uncertainty regarding El Nino and rainfall could impact flour and wheat prices in the coming season.

  • supply chain disruption · Q1 FY27

    Jyothy Labs reported: Crude oil and crude-linked derivatives remained highly volatile, impacting input costs, packaging materials, and supply chain. 90% of business linked to crude.

    Reporting period ended 2026-06-30

    17 other companies · logistics supply chain

    Marico Limited (MARICO) reported (period ended 2026-06-30): Globally volatile macro environment with supply chain disruptions and increasing energy costs impacting economic activity.

    Dabur India (DABUR) reported (period ended 2026-06-30): Impacted input cost trends and supply chain efficiency across businesses, including India; requires close monitoring.

    Radico Khaitan Limited (RADICO) reported (period ended 2026-06-30): Despite a dynamic global environment, marked by geopolitical uncertainties and supply chain challenges, the company expanded operating margins.

    United Breweries Limited (UBL) reported (period ended 2026-06-30): Middle East conflict created ~300 bps impact on GP margins, affecting packaging materials, logistics, and foreign exchange rates. Full year impact revised to INR350-400 crores.

  • demand conditions · Q1 FY27

    Jyothy Labs reported: Urban markets remained subdued due to higher household expenses, pressure on discretionary spends, and cautious consumer sentiment.

    Reporting period ended 2026-06-30

    1 other company · demand end market

    Godrej Consumer Products Limited (GODREJCP) reported (period ended 2026-06-30): El Nino could heighten weather volatility and disrupt agricultural output/rural demand, potentially affecting some categories, though the diversified portfolio offers resilience.

Mentions over time

Recorded disclosures by calendar reporting quarter
PeriodOther callsOwn calls
Q2 202601
Q4 202501
Q1 202501

Counts reflect the calls covered here. No mention in a period does not establish that a relationship ended.

From available earnings-call summaries. Disclosures are management statements, not independently verified transactions.

Live Summary

JYOTHYLAB ₹184.83 +7.52%
Guidance Verdict (11 tracked) 0 kept · 6 open· 5 missed
AI Call Brief · Q1 FY27

Jyothy Labs Q1 FY27

Overview

Symbol
NSE:JYOTHYLAB
Exchange
NSE
Currency
INR

What Jyothy Labs does

Based on the company's own presentations, annual report and earnings calls.

Jyothy Labs is a homegrown Indian FMCG company, founded in 1983, operating primarily in the Home Care and Personal Care segments across fabric care, dishwashing, household insecticides and personal care. It manufactures and markets brands including Ujala, Exo, Maxo, Margo, Henko, Mr. White, Morelight, Dr. Wool and Maya through 23 manufacturing plants and a pan-India distribution network. The company holds leading or top-two market positions in several of its core categories, including fabric whiteners, dishwash bars and mosquito-repellent coils.

Segments

  • Fabric Care
  • Dishwashing
  • Household Insecticide
  • Personal Care
  • Others
Manufacturing plants
23
Retail outlets with product availability (pan-India)
4 million+
Direct-reach outlets
1.4 million+
Channel partners
10,000+
Employees
8,300+
Market position - fabric whitener (Ujala Supreme)
#1 since launch, ~4 decades ago
Founded 1983Headquarters Ujala House, Ramkrishna Mandir Road, Kondivita, Andheri (East), Mumbai 400059 Company website

How the price took the results

Moved an average of ±1.5% across the last 4 priced result releases

Close before → close after
QuarterReleaseRevenue (₹ Cr) Net profit (₹ Cr)Rev YoYBefore → AfterReaction
Q1 FY2712 Aug 26773 48+2.9%₹204.04 → ₹200.27−1.8%
Q4 FY264 May 26717 68+7.7%₹265.64 → ₹267.9+0.9%
Q3 FY269 Feb 26740 81+5.1%₹244.18 → ₹249.96+2.4%
Q2 FY2612 Nov 25736 88+0.4%₹313.3 → ₹310.1−1.0%

The move from the last close before each results date to the first close on or after it — the market's first read on the quarter alongside what was filed.

Your own record

Start an Inve Case for Jyothy Labs

Free account: one company. Everything above stays public.

Write why you follow Jyothy Labs and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Fast Moving Consumer Goods companies

PEER COMPARISON
Median ₹6,788 Cr Mkt Cap
₹0 Cr₹5,000 Cr₹10,000 Cr₹15,000 CrJyothy Labs (JYOTHYLAB): ₹6,788 Cr₹6,788 CrJYOTHYLABKwality Wall's (India) Limited (KWIL): ₹8,928 Cr₹8,928 CrKWILThe Bombay Burmah Trading Corporation Limited (BBTC): ₹8,608 Cr₹8,608 CrBBTCKRBL Limited (KRBL): ₹8,309 Cr₹8,309 CrKRBLOrkla India Limited (ORKLAINDIA): ₹7,085 Cr₹7,085 CrORKLAINDIAGujarat Ambuja Exports Limited (GAEL): ₹6,684 Cr₹6,684 CrGAELHindustan Foods Limited (HNDFDS): ₹6,667 Cr₹6,667 CrHNDFDSGokul Agro (GOKULAGRO): ₹6,331 Cr₹6,331 CrGOKULAGRODodla Dairy (DODLA): ₹6,212 Cr₹6,212 CrDODLA

All Fast Moving Consumer Goods companies → · Fast Moving Consumer Goods earnings growth →

Quick Answers

Frequently asked questions on Jyothy Labs

Compiled directly from JYOTHYLAB's filed financial statements, earnings call transcripts, and ownership disclosures.

How did Jyothy Labs (JYOTHYLAB) perform in its latest reported quarter (Jun 2026)?

For the quarter ended Jun 2026, Jyothy Labs reported revenue of ₹773 Cr, net profit of ₹48 Cr, an operating margin of 8.0%. Diluted earnings per share stood at ₹1.3.

How is Jyothy Labs (JYOTHYLAB) valued today, and what growth does the stock price imply?

Jyothy Labs (JYOTHYLAB) trades at ₹184.83, with a market capitalization of ₹6.8k Cr. Reverse-DCF analysis shows the current stock price implies 17.8% annual earnings growth over the next 7 years compared with its historical net-profit CAGR of 11.8%.

Who owns Jyothy Labs (JYOTHYLAB) — promoters, FIIs, DIIs, and mutual funds?

As of Sept 2026, Promoters hold 62.9%, FIIs hold 14.5%, DIIs hold 9.9%, Public shareholders hold 12.8%.

Learn to analyse Jyothy Labs

Guides on how to read this kind of business and the numbers that matter.